Tech Company Financing Transactions
ENSEM Therapeutics Funding Round
On 4/6/2022, ENSEM Therapeutics announced $67 million in Series A funding from GGV Capital, CBC Capital and Cenova Capital.
Transaction Overview
Company Name
Announced On
4/6/2022
Transaction Type
Venture Equity
Amount
$67,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds will be used to further advance the company's Kinetic EnsembleTM platform and accelerate R&D pipeline.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
200 Boston Ave, Suite 1875
Medford, MA 02155
USA
Medford, MA 02155
USA
Phone
Website
Email Address
Overview
ENSEM integrates cutting edge technologies to detect and characterize rare conformational states in drug targets in motion. Such states underpin oncogenic, regulatory, and drug-resistance mechanisms, offering new opportunities for therapeutic intervention.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Sean Cao
President
Shenfang Jin
VP - Human Resources
Michael Haley
VP - Operations
Katya Henderson
Browse more venture capital transactions:
Prev: 4/6/2022: Wisewell venture capital transaction
Next: 4/6/2022: Loaded venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs